Federal regulators authorized second booster shots of the Pfizer-BioNTech and Moderna coronavirus vaccines on Tuesday for everyone 50 and older.
The Food and Drug Administration also authorized a second booster dose for individuals at least 12 years old and older with certain immune deficiencies, such as people who have undergone solid organ transplants. The agency said the additional shot can be given at least four months after a first booster for both cohorts.
As of late last week, officials were planning to present the second booster essentially as an option that older Americans or people with underlying medical conditions should consider.
Read the full article from the New York Times here.